Imogen Locke

1.5k citations

39 papers · 798 indexed · h-index 16

Impact in

Radiation top 2%
- Advanced Radiotherapy Techniques
Cancer Research top 10%
- Breast Cancer Treatment Studies

Papers in

Radiation 12
- Advanced Radiotherapy Techniques 12
Cancer Research 14
- Breast Cancer Treatment Studies 12

Co-authors: Anna M. Kirby John Yarnold Ellen M. Donovan H. McNair Philip Evans Frederick R. Bartlett Joanne Haviland R. Colgan
Journals: Clinical Oncology (9 papers)British Journal of Radiology (4 papers)Journal of Thoracic Oncology (3 papers)Radiotherapy and Oncology (2 papers)Breast Cancer Research (2 papers)
Partner nations: United Kingdom United States Australia

In The Last Decade

Imogen Locke

38 papers receiving 782 citations

Peers

Countries citing papers authored by Imogen Locke

Since Specialization

Citations

This map shows the geographic impact of Imogen Locke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Imogen Locke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Imogen Locke more than expected).

Fields of papers citing papers by Imogen Locke

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Imogen Locke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Imogen Locke. The network helps show where Imogen Locke may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Imogen Locke, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Imogen Locke Line = papers co-authored together Imogen Locke links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Oncotype DX Breast DCIS Score® Test: Impact on Radiotherapy Recommendations and Patient Decisional Anxiety Clinical Oncology ·V.G. Muhchametov, Anna M. Kirby, Imogen Locke, S. Settatree, Gargi Kothari, Pedro Henrique de Aquino Dantas, 正人浜西, ybKpD, Lars-Åke Svensson, Gill Ross, Nicola Roche	2025	1
2	Locoregional control and toxicity following high-dose hypofractionated and accelerated palliative radiotherapy regimens in breast cancer Clinical Oncology ·귀순 김, Lone Gothard, S. Zoob, Anna M. Kirby, Imogen Locke, Navita Somaiah	2023	4
3	Gross tumour volume radiomics for prognostication of recurrence & death following radical radiotherapy for NSCLC npj Precision Oncology ·Sumeet Hindocha, Andrew S. Majewski, I. I. Moiseev, Benjamin Hunter, Т.Б. Плескачева, Merina Ahmed, Kristin McRee Walker, Matthew Orton, Catey Bunce, Matthias Huber, Simon Doran, Shahreen Ahmad, Fiona McDonald, Imogen Locke, Danielle Power, Matthew Blackledge, Richard W. Lee, Eric O. Aboagye	2022	9
4	Implementation of Royal College of Radiologists Consensus Statements and National Institute for Health and Care Excellence Guidance: Breast Radiotherapy Practice in the UK Clinical Oncology ·Imogen Locke, K. Drinkwater	2021	8
5	A Comparison of Isotoxic Dose-escalated Radiotherapy in Lung Cancer with Moderate Deep Inspiration Breath Hold, Mid-ventilation and Internal Target Volume Techniques Clinical Oncology ·Sonia Baker, Alex Dunlop, Dualta Mcquaid, S. Gulliford, R. Gunapala, Merina Ahmed, Imogen Locke, Simeon Nill, Uwe Oelfke, Fiona McDonald	2021	1
6	Immune Checkpoint Inhibitor and Radiotherapy-Related Pneumonitis: An Informatics Approach to Determine Real-World Incidence, Severity, Management, and Resource Implications Frontiers in Medicine ·Sumeet Hindocha, rew Shalliker, Merina Ahmed, Sascha Warnecke, Bhupinder Sharma, Nadia Yousaf, Philip L. Molyneaux, Benjamin Hunter, Gabriel Gómez M., Wanyuan Cui, Michael Davidson, Jaishree Bhosle, Anna Minchom, Imogen Locke, Fiona McDonald, Mary O’Brien, Sanjay Popat, Richard Lee	2021	5
7	180P Incidence of brain metastases (BM) in newly diagnosed stage IV NSCLC during COVID-19 Journal of Thoracic Oncology ·Wanyuan Cui, Panchananam Lakshmi Srinivas, Garcia-Verdugo Jose Manuel, Jaishree Bhosle, Anna Minchom, Michael Davidson, Кондрашов Константин Андреевич, Imogen Locke, Nadia Yousaf, Sanjay Popat, Mary O’Brien	2021	3
8	Systemic treatment of brain metastases in non-small cell lung cancer European Journal of Cancer ·Кондрашов Константин Андреевич, Panchananam Lakshmi Srinivas, Marco Perna, Miguel Durá-Gil, Nian-Hong Jang-Liaw, Rizha Febriyanti, Merina Ahmed, Fiona McDonald, Imogen Locke, Anna Minchom, Jaishree Bhosle, Liam Welsh, Mary O’Brien	2020	75
9	18F-Fludeoxyglucose PET/CT in SCLC: Analysis of the CONVERT Randomized Controlled Trial Journal of Thoracic Oncology ·Prakash Manoharan, Ahmed Salem, Hitesh Mistry, M. Ziarno, Susan Harden, P. J. Julyan, Imogen Locke, J. McAleese, R. McMenemin, N. Mohammed, M. Snee, William H. Dougherty, Y. M. S. Udara, Corinne Faivre‐Finn	2019	20
10	OA13.01 The Impact of [18F]fludeoxyglucose PET/CT in Small-Cell Lung Cancer: Analysis of the Phase 3 CONVERT Trial Journal of Thoracic Oncology ·SHAHRIAR SAEIDI MEHRVARZ, Ahmed Salem, Hitesh Mistry, Heather Goodson, Susan Harden, P. J. Julyan, Imogen Locke, J. McAleese, R. McMenemin, N. Mohammed, M. Snee, Y. M. S. Udara, Susan L. Woods, Corinne Faivre‐Finn	2018	1
11	IMPORT Trial Management Group. Clinical impact of IMPORT HIGH trial (CRUK/06/003) on breast radiotherapy practices in the United Kingdom. British Journal of Radiology ·Y. Tsang, L. Ciurlionis, Cliona Kirwan, Anna M. Kirby, Imogen Locke, Karen Venables, John Yarnold, Jenny Titley, Judith M. Bliss, Charlotte E. Coles	2015	42
12	The Royal College of Radiologists' Audit of Prostate Brachytherapy in the Year 2012 Clinical Oncology ·Alexandra Stewart, K. Drinkwater, Robert Laing, Jenny Nobes, Imogen Locke	2015	8
13	A prospective study comparing radiographer- and clinician-based localization for patients with metastatic spinal cord compression (MSCC) to assess the feasibility of a radiographer-led service British Journal of Radiology ·Sébastien Arlotto, R. B�rger, Imogen Locke, Karen Thomas, Wan Husin, H. McNair	2015	2
14	Voluntary Breath-hold Technique for Reducing Heart Dose in Left Breast Radiotherapy Journal of Visualized Experiments ·Frederick R. Bartlett, R. Colgan, Ellen M. Donovan, Karen Carr, مهدی بیگدلو, Steven N. Maidment, H. McNair, Imogen Locke, Philip Evans, Joanne Haviland, John Yarnold, Anna M. Kirby	2014	9
15	Voluntary Breath-hold Technique for Reducing Heart Dose in Left Breast Radiotherapy Journal of Visualized Experiments ·Frederick R. Bartlett, R. Colgan, Ellen M. Donovan, Karen Carr, مهدی بیگدلو, Steven N. Maidment, H. McNair, Imogen Locke, Philip Evans, Joanne Haviland, John Yarnold, Anna M. Kirby	2014	34
16	The UK HeartSpare Study (Stage IB): Randomised comparison of a voluntary breath-hold technique and prone radiotherapy after breast conserving surgery Radiotherapy and Oncology ·Frederick R. Bartlett, R. Colgan, Ellen M. Donovan, H. McNair, Karen Carr, Philip Evans, Clare Griffin, Imogen Locke, Joanne Haviland, John Yarnold, Anna M. Kirby	2014	69
17	The carrier clinic: an evaluation of a novel clinic dedicated to the follow-up of BRCA1 and BRCA2 carriers—implications for oncogenetics practice Journal of Medical Genetics ·Elizabeth Bancroft, Imogen Locke, Audrey Ardern‐Jones, Tanner Lex Jones, Sandy Sprague, Damien Belvèze, Yolanda Barbáchano, Julian Barwell, Lyndon Walker, Geraldine M. Mitchell, Huw Dorkins, G Fannelli, J. Paterson, Четвериков Михаил Викторович, Anita Mitra, Sameer Jhavar, Mariia Tsyben, Richard S. Houlston, Susan Shanley, Rosalind A. Eeles	2010	11
18	Accurate Prediction of BRCA1 and BRCA2 Heterozygous Genotype Using Expression Profiling after Induced DNA Damage Clinical Cancer Research ·Zsofia Kote‐Jarai, Lucy Matthews, Ana Osório, Susan Shanley, Ian Giddings, François Moreews, Imogen Locke, D. Gareth Evans, Diana Eccles, Richard D. Williams, Mark Girolami, Colin Campbell, Rosalind A. Eeles	2006	29
19	Increased level of chromosomal damage after irradiation of lymphocytes from BRCA1 mutation carriers British Journal of Cancer ·Zsofia Kote‐Jarai, Asher Salmon, Diana Lucke, Michelle Copeland, Audrey Ardern‐Jones, Imogen Locke, Susan Shanley, Brenda Summersgill, Yong‐Jie Lu, Janet Shipley, Rosalind A. Eeles	2005	28
20	Ductal approaches to assessment and management of women at high risk for developing breast cancer Breast Cancer Research ·Imogen Locke, Gillian Mitchell, Rosalind A. Eeles	2004	20

About Imogen Locke

Imogen Locke is a scholar working on Radiation, Cancer Research, Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging and Oncology, having authored 39 papers that have together received 798 indexed citations. Recurring topics across this work include Advanced Radiotherapy Techniques (12 papers), Breast Cancer Treatment Studies (12 papers), Lung Cancer Diagnosis and Treatment (10 papers), BRCA gene mutations in cancer (8 papers), Lung Cancer Treatments and Mutations (8 papers), Advances in Oncology and Radiotherapy (5 papers), Global Cancer Incidence and Screening (4 papers) and Brain Metastases and Treatment (4 papers). The work is most often cited by research in Radiation (298 citations), Cancer Research (288 citations), Radiology, Nuclear Medicine and Imaging (246 citations), Pulmonary and Respiratory Medicine (301 citations) and Oncology (208 citations). Imogen Locke has collaborated with scholars based in United Kingdom, United States and Australia. Frequent co-authors include Anna M. Kirby, John Yarnold, Ellen M. Donovan, H. McNair, Philip Evans, Frederick R. Bartlett, Joanne Haviland, R. Colgan, Karen Carr and Rosalind A. Eeles. Their work appears in journals such as Clinical Oncology, British Journal of Radiology, Journal of Thoracic Oncology, Radiotherapy and Oncology and Breast Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact